Zimmer Biomet Holdings (ZBH) Shares Outstanding (Weighted Average) (2009 - 2026)
Zimmer Biomet Holdings (ZBH) recorded quarterly Shares Outstanding (Weighted Average) of $195.0 million in Q1 2026, down 1.52% quarter-over-quarter from $198.0 million in Q4 2025, and down 1.96% on a YoY basis from $198.9 million in Q1 2025.
Zimmer Biomet Holdings (ZBH) Shares Outstanding (Weighted Average) (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Shares Outstanding (Weighted Average) history runs 11 years deep, the most recent figure standing at $195.0 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) fell 1.96% year-over-year to $195.0 million; the TTM figure through Mar 2026 stood at $195.0 million (down 1.96% YoY), while the FY2025 annual figure was $198.0 million, down 2.51% from the prior year.
- Shares Outstanding (Weighted Average) was $195.0 million for Q1 2026 at Zimmer Biomet Holdings, down from $198.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $209.8 million in Q3 2022 to a low of $195.0 million in Q1 2026.
- Historically, Shares Outstanding (Weighted Average) has averaged $204.0 million across 5 years, with a median of $205.2 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Weighted Average) retreated 0.38% in 2023, then declined 3.41% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $209.6 million in 2022, then declined by 0.43% to $208.7 million in 2023, then fell by 2.68% to $203.1 million in 2024, then declined by 2.51% to $198.0 million in 2025, then declined by 1.52% to $195.0 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $195.0 million (Q1 2026), $198.0 million (Q4 2025), and $198.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 579.20 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 456.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 385.10 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Zimmer Biomet Holdings | 17.27 Bn | 16.86 Bn | 1.51 Bn | 195.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 195.00 Mn |
| Dec 31, 2025 | 198.00 Mn |
| Sep 30, 2025 | 198.30 Mn |
| Jun 30, 2025 | 198.40 Mn |
| Mar 31, 2025 | 198.90 Mn |
| Dec 31, 2024 | 203.10 Mn |
| Sep 30, 2024 | 202.30 Mn |
| Jun 30, 2024 | 205.40 Mn |
| Mar 31, 2024 | 205.20 Mn |
| Dec 31, 2023 | 208.70 Mn |
| Sep 30, 2023 | 209.00 Mn |
| Jun 30, 2023 | 208.60 Mn |
| Mar 31, 2023 | 209.40 Mn |
| Dec 31, 2022 | 209.60 Mn |
| Sep 30, 2022 | 209.80 Mn |
| Sep 30, 2014 | 169.00 Mn |
| Jun 30, 2014 | 168.40 Mn |
| Mar 31, 2014 | 169.10 Mn |
| Dec 31, 2013 | 169.60 Mn |
| Sep 30, 2013 | 170.00 Mn |